LeadIQ logo
Learn more at LeadIQ.com

Insights

Loading spinner
Gathering insights about MBX Biosciences, Inc.…

MBX Biosciences, Inc. Tech Stack

MBX Biosciences, Inc. uses 8 technology products and services including SAS/STAT, Unpkg, NetSuite, and more. Explore MBX Biosciences, Inc.'s tech stack below.

  • SAS/STAT
    Advanced Analytics And Data Science
  • Unpkg
    Content Delivery Network
  • NetSuite
    E-commerce
  • Veeva Vault
    Enterprise Content Management
  • AOS
    Javascript Libraries
  • Office 365
    Office Suites
  • PHP
    Programming Languages
  • Smartsheet
    Project Management

Media & News

MBX Biosciences, Inc.'s Email Address Formats

MBX Biosciences, Inc. uses at least 1 format(s):
MBX Biosciences, Inc. Email FormatsExamplePercentage
FLast@mbxbio.comJDoe@mbxbio.com
46%
First@mbxbio.comJohn@mbxbio.com
7%
FirstLast@mbxbio.comJohnDoe@mbxbio.com
1%
FLast@mbxbio.comJDoe@mbxbio.com
46%

Frequently Asked Questions

What is MBX Biosciences, Inc.'s official website and social media links?

Minus sign iconPlus sign iconMBX Biosciences, Inc.'s official website is mbxbio.com and has social profiles on LinkedInCrunchbase.

What is MBX Biosciences, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign iconMBX Biosciences, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does MBX Biosciences, Inc. have currently?

Minus sign iconPlus sign iconAs of December 2025, MBX Biosciences, Inc. has approximately 62 employees across 2 continents, including North AmericaAsia. Key team members include Chief Human Resources Officer: M. G.Chief Medical Officer: S. S. A.Chief Financial Officer: R. B.. Explore MBX Biosciences, Inc.'s employee directory with LeadIQ.

What industry does MBX Biosciences, Inc. belong to?

Minus sign iconPlus sign iconMBX Biosciences, Inc. operates in the Biotechnology Research industry.

What technology does MBX Biosciences, Inc. use?

Minus sign iconPlus sign iconMBX Biosciences, Inc.'s tech stack includes SAS/STATUnpkgNetSuiteVeeva VaultAOSOffice 365PHPSmartsheet.

What is MBX Biosciences, Inc.'s email format?

Minus sign iconPlus sign iconMBX Biosciences, Inc.'s email format typically follows the pattern of FLast@mbxbio.com. Find more MBX Biosciences, Inc. email formats with LeadIQ.

How much funding has MBX Biosciences, Inc. raised to date?

Minus sign iconPlus sign icon As of December 2025, MBX Biosciences, Inc. has raised $64M in funding. The last funding round occurred on Aug 05, 2024 for $64M.

When was MBX Biosciences, Inc. founded?

Minus sign iconPlus sign iconMBX Biosciences, Inc. was founded in 2019.

MBX Biosciences, Inc.

Biotechnology ResearchIndiana, United States51-200 Employees

MBX Biosciences, Inc. is a clinical stage biopharmaceutical company pioneering investigational Precision Endocrine Peptides (PEPs™). PEPs are designed to overcome key limitations of native peptide therapeutics to deliver superior pharmacologic properties. MBX is advancing a pipeline of PEP candidates to address the unmet needs of people with endocrine disorders. The company’s lead product candidate, MBX 2109 for the treatment of hypoparathyroidism, is currently in a Phase 1 clinical trial. Members of MBX’s leadership team have collaborated over several decades on the discovery, development, and commercialization of highly successful endocrine therapeutics including Forteo® and Humalog®. The company is supported by leading life science investors including Frazier Life Sciences, New Enterprise Associates and OrbiMed.

Section iconCompany Overview

Website
mbxbio.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2019
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $64M

    MBX Biosciences, Inc. has raised a total of $64M of funding over 4 rounds. Their latest funding round was raised on Aug 05, 2024 in the amount of $64M.

  • $25M$50M

    MBX Biosciences, Inc.'s revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $64M

    MBX Biosciences, Inc. has raised a total of $64M of funding over 4 rounds. Their latest funding round was raised on Aug 05, 2024 in the amount of $64M.

  • $25M$50M

    MBX Biosciences, Inc.'s revenue is estimated to be in the range of $25M$50M

Company Leadership

  • Stylized image of a person
    M. G.
    Chief Human Resources Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    S. S. A.
    Chief Medical Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    R. B.
    Chief Financial Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    K. G.
    Vice President Of Quality
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. G.
    Vice President Marketing
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    D. S.
    Vice President
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. G.
    Vice President Marketing
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. W.
    Vice President Medicinal Chemistry
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. S.
    Associate Director, Talent Acquisition
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. D.
    Senior Director, Investor Relations & Communications
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.